Terms: = Liver cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Diagnosis
22 results:
1. Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancer.
Kut E; Menekse S
Sci Rep; 2024 Jan; 14(1):1371. PubMed ID: 38228667
[TBL] [Abstract] [Full Text] [Related]
2. Clinical application value of hepatitis B virus basal core promoter 1762/1764 and GGTII and GGT in patients with HBV-DNA-positive primary liver cancer.
Qiu S; Jin L; Yang D; Zhang D
Medicine (Baltimore); 2023 Oct; 102(43):e35699. PubMed ID: 37904480
[TBL] [Abstract] [Full Text] [Related]
3. Predicting glypican-3 expression in hepatocellular carcinoma: A comprehensive analysis using combined contrast-enhanced ultrasound and clinical factors.
Li N; Dong T; Wang P; Li Q; Nie F
Clin Hemorheol Microcirc; 2023; 85(4):407-420. PubMed ID: 37638421
[TBL] [Abstract] [Full Text] [Related]
4. The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis.
Wu T; Fan R; Bai J; Yang Z; Qian YS; Du LT; Wang CY; Wang YC; Jiang GQ; Zheng D; Fan XT; Zheng B; Liu JF; Deng GH; Shen F; Hu HP; Ye YN; Zhang QZ; Zhang J; Gao YH; Xia J; Yan HD; Liang MF; Yu YL; Sun FM; Gao YJ; Sun J; Zhong CX; Wang Y; Wang H; Kong F; Chen JM; Wen H; Wu BM; Wang CX; Wu L; Hou JL; Liu XL; Wang HY; Chen L
J Hematol Oncol; 2023 Jan; 16(1):1. PubMed ID: 36600307
[TBL] [Abstract] [Full Text] [Related]
5. Factors affecting prognosis in hepatocellular carcinoma patients post-transarterial chemoembolization.
Prateepchaiboon T; Chang A; Pungpipattrakul N; Akarapatima K; Rattanasupar A; Songjamrat A; Pakdeejit S; Piratvisuth T
Indian J Gastroenterol; 2022 Aug; 41(4):352-361. PubMed ID: 36029371
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes of Patients with Necrotizing Soft Tissue Infections: A Propensity-Matched Analysis Using the National Inpatient Sample.
Collins CM; McCarty A; Jalilvand A; Strassels S; Schubauer K; Gonzalez-Gallo K; Young A; Wisler J
Surg Infect (Larchmt); 2022 Apr; 23(3):304-312. PubMed ID: 35196155
[No Abstract] [Full Text] [Related]
7. Fine needle aspiration of hepatic angiomyolipoma with extramedullary hematopoiesis: A case report.
Baumgartner E; Garapati M; Sanders R; Eloubeidi M; Rosenblum F
Cytopathology; 2022 Jul; 33(4):534-539. PubMed ID: 35075721
[TBL] [Abstract] [Full Text] [Related]
8. Substantial gaps in evaluation and treatment of patients with hepatitis B in the US.
Ye Q; Kam LY; Yeo YH; Dang N; Huang DQ; Cheung R; Nguyen MH
J Hepatol; 2022 Jan; 76(1):63-74. PubMed ID: 34474097
[TBL] [Abstract] [Full Text] [Related]
9. [The value of serum glypican-3 level in aided diagnosis of patients with primary hepatocellular carcinoma].
Tang XY; Wang YC; Lu RQ; Guo L
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):998-1002. PubMed ID: 32907292
[No Abstract] [Full Text] [Related]
10. Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan.
Hsu CS; Lang HC; Huang KY; Chao YC; Chen CL
Hepatol Int; 2018 Nov; 12(6):531-543. PubMed ID: 30426396
[TBL] [Abstract] [Full Text] [Related]
11. A Comparative Analysis of Survival and Funding Discrepancies in cancers With High Mortality.
Hall BR; Cannon A; Atri P; Wichman CS; Smith LM; Kumar S; Batra SK; Wang H; Ganti AK; Sasson AR; Are C
Ann Surg; 2020 Feb; 271(2):296-302. PubMed ID: 30188400
[TBL] [Abstract] [Full Text] [Related]
12. Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan.
Nishie A; Goshima S; Haradome H; Hatano E; Imai Y; Kudo M; Matsuda M; Motosugi U; Saitoh S; Yoshimitsu K; Crawford B; Kruger E; Ball G; Honda H
Clin Ther; 2017 Apr; 39(4):738-750.e4. PubMed ID: 28363694
[TBL] [Abstract] [Full Text] [Related]
13. Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.
Liu F; Meng Z; Shao G; Wang J; Wang Z; Yang J; Yip CS; He D
Mol Biol Rep; 2017 Feb; 44(1):149-158. PubMed ID: 27981445
[TBL] [Abstract] [Full Text] [Related]
14. Long-term follow-up of HBsAg-positive patients in Germany.
Niederau C; Amani A; Thiel A
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):48-56. PubMed ID: 26445381
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
Zhao Y; Li Y; Hu B; He X; Huang J; Zhan M; Lu L
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):390-2. PubMed ID: 24746091
[TBL] [Abstract] [Full Text] [Related]
16. Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.
Hsu CY; Lee YH; Liu PH; Hsia CY; Huang YH; Lin HC; Chiou YY; Lee FY; Huo TI
PLoS One; 2014; 9(2):e89373. PubMed ID: 24586728
[TBL] [Abstract] [Full Text] [Related]
17. [Bilateral metastases of renal cell carcinoma to the ovaries--a case report].
Hołody-Zareba J; Kinalski P; Sulkowski S; Kozłowski R; Kinalski M
Ginekol Pol; 2013 Jul; 84(7):650-3. PubMed ID: 24032280
[TBL] [Abstract] [Full Text] [Related]
18. Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer.
Wang J; Ma L; Weng W; Qiao Y; Zhang Y; He J; Wang H; Xiao W; Li L; Chu Q; Pan Q; Yu Y; Sun F
Hepatology; 2013 Sep; 58(3):1011-20. PubMed ID: 23532963
[TBL] [Abstract] [Full Text] [Related]
19. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2012 May; 344():e3427. PubMed ID: 22619194
[TBL] [Abstract] [Full Text] [Related]
20. FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma.
Higashi T; Hatano E; Ikai I; Nishii R; Nakamoto Y; Ishizu K; Suga T; Kawashima H; Togashi K; Seo S; Kitamura K; Takada Y; Uemoto S
Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):468-82. PubMed ID: 19838700
[TBL] [Abstract] [Full Text] [Related]
[Next]
